# Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM

> **NCT02555007** · PHASE1 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 30 (actual)

## Conditions studied

- Non Small Cell Lung Cancer (NSCLC)
- Malignant Pleural Mesothelioma (MPM)

## Interventions

- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT02555007
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-26
- **Primary completion:** 2018-07-26
- **Final completion:** 2022-10-25
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02555007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02555007, "Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02555007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*